🇺🇸 FDA
Pipeline program

A Study of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment

J2S-MC-GZML

Phase 1 other active

Quick answer

A Study of LY3537031 in Participants With Normal Liver Function and With Mild, Moderate, or Severe Liver Impairment for Healthy, Hepatic Insufficiency is a Phase 1 program (other) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).

Program details

Company
Eli Lilly Co.
Indication
Healthy, Hepatic Insufficiency
Phase
Phase 1
Modality
other
Status
active

Clinical trials